US 11633488
Modified IL-2 polypeptides and uses thereof
granted A61KA61K38/2013A61K47/60
Quick answer
US patent 11633488 (Modified IL-2 polypeptides and uses thereof) held by Bright Peak Therapeutics AG expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bright Peak Therapeutics AG
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/2013, A61K47/60, A61P, A61P35/00